fbpx
curas

Q-SWITCHED nd:yag 1064NM & 532NM

New Generation Q-Switched Nd:YAG Laser with ReGenesis Mode and MLA Handpiece

Product description

NEW & ADVANCED Q-SWITCHED FEATURES. PRECISION. POWER. VERSATILITY.

CuRAS is the newest and most advanced Q-Switched Laser that provides the optimal performance for the treatment of tattoos, melasma,
non-ablative resurfacing and pigmented lesions. The new ReGENESIS treatment combines different pulse modes allowing you to target a wide range
of different skin concerns in one single CuRAS treatment. 

FEATURES

  • MLA Handpiece
  • M-Pulse (Medical Indications)
  • A-Pulse (Aesthetic Indications) 
  • Largest Spot Size
  • Fastest Pulse Repetition
  • 4 Different Pulse Durations

INDICATIONS

  • Tattoo Removal
  • Pigmented Lesions
  • Melasma
  • Carbon Peel/China Doll Facial
  • Skin Rejuvenation
  • Onychomycosis
  • Nevus of Ota
  • Cafe au Lait
  • Lentingo
  • Freckles
  • Post-inflammatory hyperpigmentation

 

CuRAS HANDPIECES

CuRAS ReGENESIS™

 CuRAS exclusive ReGENESISTM treatment allows practitioners to target the seven layers of ageing with a synergistic approach for maximum results. With four monthly treatments, the ReGENESISTM  treatment utilises unique pulse modes and the MLA handpiece to target a multitude of concerns in a single treatment.

Product Videos and features

CuRAS VIDEO

CuRAS PREMIUM MODES

 

Technology Highlight

Energy Stability Q1064

CuRAS superior energy stability and perfect beam profile enables stable thermal energy delivery to the target area for long treatment time resulting in uniform clinical efficacy and minimising damage to surrounding tissue.

Clinical results

Clinical Results

Testimonials

This Q-switched Nd:YAG laser system provides an efficient treatment for age or solar related lentigines and pigmented lesions, as well as reduction of pores. While the 1064nm Nd:YAG laser can be used for pigmented dermal lesions, pore reduction and skin rejuvenation, the 1064 nm / 532 nm combination is an effective choice for solar lentigines.

Professor Cemal Tahsin Gokhur Senyuva, M.D.

Our initial trial on the difference of reaction from CuRAS expert mode M-1064 shows promising results in terms of safety and efficacy for melasma in Southeast Asian patients.

Abraham Arimuko M.D

Complementary devices

Chat Now
mail
call